In a separate cohort of 87 non-HCC and 78 HCC patients, a 6-marker panel, including GSTP1 and RASSF1A, achieved an AUROC of 0.908 for HCC detection, surpassing the AUROC of 0.841 for AFP alone. Here, AFP is linked to hepatocellular carcinoma.